Skip to main content
. 2010 Mar 1;67(5):439–445. doi: 10.1016/j.biopsych.2009.11.001

Figure 2.

Figure 2

(A) Chocolate in the mouth with the sight of chocolate (reboxetine [Rebox] > placebo [Plac]): axial, sagittal, and coronal image of increased medial orbitofrontal cortex/frontal pole activation in the reboxetine group compared with the placebo ([10 42 −30], z = 3.01, p = .05 false discovery rate small volume corrected). (B) Parameter estimates from 6-mm sphere centered at 10 42 −30 for citalopram (Cital), reboxetine, and placebo.